top of page

Alzheimer's Disease Detection Study

Clinical trial evaluating the effectiveness of a blood test for early detection and diagnosis of Alzheimer's Dementia. 

Eastside Research Associates has partnered with a sponsor to study the effectiveness of a blood test to detect the presence of a biomarker that can aid in early detection and diagnosis of Alzheimer's Dementia.


Participants enrolled in this study will undergo a CT and MRI scan, lumbar puncture for cerebral spinal fluid sampling and a blood draw.


Participants enrolled in this new clinical research study receive free evaluation and will also be compensated for their time.

Participant Enrollment Criteria
  • 55 to 80 years of age

  • Mild cognitive complaints and and memory impairment

  • Willing to undergo a blood draw, CT and MRI imaging and a lumbar puncture.

  • Additional criteria apply

Participants Will Receive
  • Paid compensation up to $600 for time and effort.

Location and Time
  • 3 total visits; each  approximately 2-4 hours in length

  • Eastside Research Associates in Redmond, WA and imaging center

Once you complete the self-screening questionnaire, our expert recruiting team will call and discuss the outline of the study, time commitment and compensation plan. Once enrolled, participants will be under the careful guidance and care of our physicians and clinical staff for monitoring and data collection through the duration of the study.

If you are interested in participating in this study or have questions about your eligibility, please use the form below or contact our study recruitment team.

Interested in future studies?

Join our participant list using the link below if you are interested in becoming a study participant for other current or future studies offered by ERA.

bottom of page